Henry Kanarek, MD
Allergy & Immunology · Overland Park, KSNPI 1801983408
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Pharming Healthcare, Inc. at 41.8% of the total. Among allergy & immunology clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 2,388 payments — averaging $59.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharming Healthcare, Inc.$60K
- Biocryst US Sales Co., LLC$29K
- AstraZeneca$15K
- CSL Behring$6K
- Biocryst Pharmaceuticals, Inc.$6K
- Teva Pharmaceuticals USA, Inc.$3K
- plus $24K from 54 others
Across 687 payments — averaging $1102.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$274K
- Regeneron$122K
- ADMA Biomanufacturing LLC$121K
- Kedrion S.p.a.$101K
- Novartis$82K
- Octapharma USA, Inc.$24K
- plus $33K from 3 others
What the payments were for
- Consulting fees$21,70815%
- Speaking & faculty fees$80,92557%
- Travel & lodging$4,2683%
- Food & beverage$35,71625%
- Education$3090%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RUCONEST$58,506
- Orladeyo$30,326
- FASENRA$10,226
- Haegarda$4,596
- ArmonAir Digihaler$1,680
- ProAir Digihaler$1,680
- AirDuo RespiClick$1,680
- BREZTRI$829
- TEZSPIRE$669
- TAKHZYRO$600
- AIRSUPRA$316
- Brinsupri$251
- SYMBICORT$177
- CALQUENCE$176
- BEVESPI AEROSPHERE$176
- FARXIGA$160
How this compares
$142,927 in reported general payments places this provider in the 95th percentile of 33 allergy & immunology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KalbitorEcallantide | 16 | $3,512,618 |
| OrladeyoBerotralstat Hydrochloride | 76 | $3,170,407 |
| RuconestC1 Esterase Inhibitor, Recomb | 13 | $1,608,203 |
| FirazyrIcatibant Acetate | 14 | $1,258,588 |
| TakhzyroLanadelumab-Flyo | 16 | $865,171 |
| HaegardaC1 Esterase Inhibitor | 11 | $599,215 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 118 | $89,251 |
| Dupixent PenDupilumab | 14 | $61,809 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 50 | $37,324 |
| Breo ElliptaFluticasone/Vilanterol | 39 | $16,892 |
| MotegrityPrucalopride Succinate | 12 | $12,475 |
| SymbicortBudesonide/Formoterol Fumarate | 39 | $12,419 |
| Cevimeline Hcl | 40 | $10,096 |
| Omeprazole | 636 | $9,416 |
| Pilocarpine Hcl | 67 | $8,331 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Shire North American Group IncKalbitor | $202 | $3,512,61816 claims |
| Biocryst US Sales Co., LLCOrladeyo | $28,647 | $3,170,40776 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Firazyr, Takhzyro, Motegrity | $2,058 | $2,136,23442 claims |
| Pharming Healthcare, Inc.Ruconest | $59,755 | $1,608,20313 claims |
| CSL BehringHaegarda | $6,374 | $599,21511 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $2,121 | $106,143157 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $14,563 | $49,74389 claims |
| AbbVieRestasis | $2,771 | $7,61414 claims |
| Boehringer IngelheimSpiriva Respimat | $182 | $7,20514 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 33 allergy & immunology providers in Kansas.
Other allergy & immunology in Overland Park
- Celina BernabeOverland Park$95K
- William LaveryOverland Park$25K
- Sara AzzamOverland Park$19K
- Nguyen TranOverland Park$15K
- Cori PasserOverland Park$14K
- Derrick WardOverland Park$6K
- Mark NeustromOverland Park$3K
- James SternerOverland Park$3K
- H LevineOverland Park$3K
- Khaled GirgisOverland Park$636
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.